W. Cleare et al., In vitro and in vivo stability a Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies, INFEC IMMUN, 67(6), 1999, pp. 3096-3107
The monoclonal antibody (MAb) 2H1 defines an epitope in Cryptococcus neofor
mans capsular glucuronoxylomannan (GXM) that can elicit protective antibodi
es. In murine models of cryptococcosis, MAb 2H1 administration prolongs sur
vival and reduces fungal burden but seldom clears the infection, The mechan
ism by which C. neoformans persists and escape antibody-mediated clearance
is not understood. One possibility is that variants that do not bind MAb 2H
1 emerge in the course of infection. Using an agglutination-sedimentation p
rotocol, we recovered a variant of strain 24067 that did mt agglutinate, co
uld not be serotyped, and had marked reduction in GXM O-acetyl groups. Bind
ing of MAb 2H1 to 24067 variant cells produced a different immunofluorescen
ce pattern and lower fluorescence intensity relative to the parent 24067 ce
lls. Addition of MAb 2H1 to 24067 variant cells had no effect on cell charg
e. Phagocytic assays demonstrated that MAb 2H1 was not an effective opsonin
for the 24067 variant. The 24067 variant was less virulent than the 24067
parent strain in mice, and MAb 2H1 administration did not prolong survival
in animals infected with the variant strain. To investigate whether variant
s which do not bind MAb 2H1 are selected in experimental infection, three C
. neoformans strains mere serially passaged in mice given either MAb 2H1 or
no antibody. Analysis of passaged isolates by agglutination assay, Bow cyt
ometry, and indirect immunofluorescence revealed changes in MAb 2H1 epitope
expression but no clear trend with regards to gain or loss of MAb 2H1 epit
ope. C. neoformans variants with reduced MAb 2H1 epitope content can be iso
lated in vitro, but persistence of infection in mice given MAb 2H1 does not
appear to be a result of selection of escape variants that lack the MAb 2H
1 epitope.